BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Staging
18 results:

  • 1. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.
    Mehanna H; Taberna M; von Buchwald C; Tous S; Brooks J; Mena M; Morey F; Grønhøj C; Rasmussen JH; Garset-Zamani M; Bruni L; Batis N; Brakenhoff RH; Leemans CR; Baatenburg de Jong RJ; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Alemany L;
    Lancet Oncol; 2023 Mar; 24(3):239-251. PubMed ID: 36796393
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary Dermal Melanoma: A Case Report.
    Weiss A; Christensen RE; Maghari A; Wassef C
    Am J Dermatopathol; 2022 Mar; 44(3):212-214. PubMed ID: 34726186
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Setting the stage: Contemporary staging of non-melanomatous skin cancer and implementation of the new American Joint Committee on cancer eighth edition staging manual.
    Casswell G; Cavanagh K; Ravi Kumar AS; Giddings C; McDowell L
    Oral Oncol; 2019 Nov; 98():102-108. PubMed ID: 31574414
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).
    ; Monden N; Asakage T; Kiyota N; Homma A; Matsuura K; Hanai N; Kodaira T; Zenda S; Fujii H; Tahara M; Yokota T; Akimoto T; Iwae S; Onitsuka T; Ogawa T; Okano S; Takahashi S; Shimizu Y; Yonezawa K; Hayashi R
    Jpn J Clin Oncol; 2019 Jul; 49(7):589-595. PubMed ID: 31194232
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):237-247. PubMed ID: 29332704
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [The 8th edition of the AJCC cancer staging Manual : Updates in otorhinolaryngology, head and neck surgery].
    Doescher J; Veit JA; Hoffmann TK
    HNO; 2017 Dec; 65(12):956-961. PubMed ID: 28717958
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Multiple cutaneous melanomas associated with gastric and brain metastases.
    Grander LC; Cabral F; Lisboa AP; Vale G; Barcaui CB; Maceira JM
    An Bras Dermatol; 2016; 91(5 suppl 1):98-100. PubMed ID: 28300909
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions.
    Marinescu A; Stepan AE; Mărgăritescu C; Marinescu AM; Zăvoi RE; Simionescu CE; Niculescu M
    Rom J Morphol Embryol; 2016; 57(2 Suppl):691-696. PubMed ID: 27833960
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lymph node melanocytic nevi: pathogenesis and differential diagnoses, with special reference to p16 reactivity.
    Piana S; Tagliavini E; Ragazzi M; Zanelli M; Zalaudek I; Ciarrocchi A; Valli R
    Pathol Res Pract; 2015 May; 211(5):381-8. PubMed ID: 25661066
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differential expression of degradome components in cutaneous squamous cell carcinomas.
    Prasad NB; Fischer AC; Chuang AY; Wright JM; Yang T; Tsai HL; Westra WH; Liegeois NJ; Hess AD; Tufaro AP
    Mod Pathol; 2014 Jul; 27(7):945-57. PubMed ID: 24356192
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
    Segura MF; Greenwald HS; Hanniford D; Osman I; Hernando E
    Carcinogenesis; 2012 Oct; 33(10):1823-32. PubMed ID: 22693259
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic prediction of the immunohistochemical expression of p16 and p53 in cutaneous melanoma: a comparison of two populations from different geographical regions.
    Sirigu P; Piras F; Minerba L; Murtas D; Maxia C; Colombari R; Corbu A; Perra MT; Ugalde J
    Eur J Histochem; 2006; 50(3):191-8. PubMed ID: 16920642
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumours of familial origin in the head and neck.
    Suárez C; Rodrigo JP; Ferlito A; Cabanillas R; Shaha AR; Rinaldo A
    Oral Oncol; 2006 Nov; 42(10):965-78. PubMed ID: 16857415
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.
    Mihic-Probst D; Mnich CD; Oberholzer PA; Seifert B; Sasse B; Moch H; Dummer R
    Int J Cancer; 2006 May; 118(9):2262-8. PubMed ID: 16331607
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Sentinel node biopsy. What are the facts?].
    Möhrle M; Breuninger H
    Hautarzt; 2005 May; 56(5):441-7. PubMed ID: 15887051
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cutaneous melanoma.
    Thompson JF; Scolyer RA; Kefford RF
    Lancet; 2005 Feb 19-25; 365(9460):687-701. PubMed ID: 15721476
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Melanoma in children and adolescents.
    Pappo AS
    Eur J Cancer; 2003 Dec; 39(18):2651-61. PubMed ID: 14642927
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.